Table 1.
Global anti-hepatitis C virus prevalence and number of infected individuals (all ages)
| Continent | Anti- HCV prevalence (%) | Viraemic rate (%) | 2013 population (millions) | Anti- HCV infected (millions) | Viraemic HCV infected (millions) |
| Africa | 2.9 | 70.5 | 927.0 | 26.9 | 19.0 |
| North Africa/Middle East | 2.7 | 68.8 | 469.0 | 12.7 | 8.7 |
| America | 1.3 | 74.0 | 953.7 | 12.4 | 9.2 |
| Asia | 2.8 | 64.4 | 3985.0 | 111.6 | 71.9 |
| Australasia | 1.8 | 74.8 | 28.0 | 0.5 | 0.4 |
| Europe | 1.8 | 72.4 | 742.5 | 13.4 | 9.7 |
| Total | 2.5 | 67.0 | 7105.2 | 177.5 | 118.9 |
HCV: Hepatitis C virus.